Obesity Therapy Following S3 Guidelines
Obesity is a chronic disease with neurobiological, hormonal, and environmental factors — not primarily a matter of willpower. The S3 Guidelines AWMF 050-001 (Update 2024) from German professional societies[1] recommend a multimodal therapy that integrates medical, nutritional, movement-based, and behavioral medicine aspects.
Structured, Physician-Guided Weight Loss
Sustainable weight loss does not work with crash diets or short-term measures. We recommend long-term structured weight loss for:
- BMI ≥ 30 kg/m² (obesity grade I-III), or
- BMI ≥ 27 kg/m² with comorbidities (arterial hypertension, type 2 diabetes, metabolic syndrome, OSA)
The goal is a weight loss of 5-10% within 6-12 months. Already this moderate reduction leads, according to the S3 Guidelines[1], to measurable improvements: improved insulin resistance and blood glucose control, blood pressure reduction, improved blood lipids, and reduction of the severity of obstructive sleep apnea.
What the Treatment Includes
- Medical History & Goal Setting: Assessment of weight history, comorbidities, medications, psychosocial factors, and realistic goal setting.
- Nutritional Medicine Consultation: Counseling by a physician with additional qualification in nutritional medicine — specifically: what you eat, why, and what can realistically be changed?
- Movement Concept: Recommendations that fit your daily life — not the standard sheet with 10,000 steps.
- Behavioral Medicine Aspects: Support for behavioral changes, management of stressors, emotional eating, and psychological barriers.
- Medication Options: If needed, GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) as an individual health service (IGeL) with complete cost transparency in advance.
- Supportive Diagnostics: Laboratory tests, blood pressure monitoring, body composition analysis (BIA), and sleep diagnostics if needed to assess sleep apnea.
One principle has proven helpful in practice: one change per appointment. We don't turn your whole life upside down at once — we work step by step on what is realistically sustainable in your daily routine, and check at the next visit what worked and what didn't.
dr. med. univ. Albrecht Wenzel is a certified obesity specialist (DAG-DDG, 2024) and an active member of the German Obesity Society (DAG). Treatment is based on the current S3 Guidelines on Obesity (AWMF 050-001).
Why sleep must be considered in obesity treatment
The importance of sleep for weight regulation is often underestimated. Sleep deprivation and sleep disorders affect metabolism through several mechanisms:
- Increased ghrelin secretion (appetite hormones) and decreased leptin levels[2] → increased appetite and altered satiety. A University of Chicago study showed: just 1.2 additional hours of sleep per night reduced daily calorie intake by approximately 270 kcal[5]
- Promotion of visceral fat deposition (the most harmful form of abdominal fat) and worsening of insulin sensitivity — both independent risk factors for type 2 diabetes and cardiovascular disease[3,6]
Obesity is the main risk factor for obstructive sleep apnea (OSA)[3,4]. Conversely, OSA can increase body weight. Therefore, we integrate sleep diagnostics and therapy into obesity treatment.
GLP-1 receptor agonists (semaglutide, tirzepatide) are not reimbursable for obesity without type 2 diabetes. Medical guidance is provided within the extended internal medicine consultation (Thursdays).
Billing follows the GOÄ; before the service is provided, we conclude a written agreement in accordance with § 18 (8) BMV-Ä with transparent cost information — including treatment duration, dosage, and follow-up diagnostics.
References
- S3 Guidelines on Obesity — Prevention and Treatment. AWMF Registry No. 050-001, German Obesity Society (DAG), updated 2024.
- Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846–850.
- S3 Guidelines on Sleep-Related Breathing Disorders in Adults. AWMF Registry No. 063-001, German Society for Sleep Research and Sleep Medicine (DGSM), 2017.
- Peppard PE, Young T, Palta M et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23):3015–3021.
- Tasali E, Wroblewski K, Kahn E et al. Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings. JAMA Intern Med. 2022;182(4):365–374.
- Reutrakul S, Van Cauter E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018;84:56–66.
Contact & Office Hours
Book an appointment or contact us
Contact Information
04159 Leipzig
Office Hours
| Monday | 07:00 – 12:00 12:30 – 15:00 |
|---|---|
| Tuesday | 07:00 – 12:00 13:00 – 18:00 |
| Wednesday | 07:00 – 12:00 12:30 – 15:00 |
| Thursday | 08:00 – 12:00 13:00 – 16:00 (private, by appt.) |
| Friday | 08:00 – 12:00 |
Note: Reachable by phone during office hours at 0341 5210871